N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma.
Studying the early stages of cancer can provide important insight into the molecular basis of the disease. We identified a preneoplastic stage in the patched (ptc) mutant mouse, a model for the brain tumor medulloblastoma. Preneoplastic cells (PNCs) are found in most ptc mutants during early adulthood, but only 15% of these animals develop tumors. Although PNCs are found in mice that develop tumors, the ability of PNCs to give rise to tumors has never been demonstrated directly, and the fate of cells that do not form tumors remains unknown. Using genetic fate mapping and orthotopic transplantation, we provide definitive evidence that PNCs give rise to tumors, and show that the predominant fate of PNCs that do not form tumors is differentiation. Moreover, we show that N-myc, a gene commonly amplified in medulloblastoma, can dramatically alter the fate of PNCs, preventing differentiation and driving progression to tumors. Importantly, N-myc allows PNCs to grow independently of hedgehog signaling, making the resulting tumors resistant to hedgehog antagonists. These studies provide the first direct evidence that PNCs can give rise to tumors, and demonstrate that identification of genetic changes that promote tumor progression is critical for designing effective therapies for cancer.
Kessler
Jessica D
JD
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Hasegawa
Hiroshi
H
Brun
Sonja N
SN
Emmenegger
Brian A
BA
Yang
Zeng-Jie
ZJ
Dutton
John W
JW
Wang
Fan
F
Wechsler-Reya
Robert J
RJ
D000818:Animals; D002454:Cell Differentiation / Q000502:physiology*; D002465:Cell Movement; D049109:Cell Proliferation; D002531:Cerebellum / Q000166:cytology; D004195:Disease Models, Animal; D015870:Gene Expression; D017930:Genes, Reporter; D053823:Hedgehog Proteins / Q000037:antagonists & inhibitors; D008527:Medulloblastoma / Q000473:pathology*; D051379:Mice; D016513:Mice, SCID; D008822:Mice, Transgenic; D011230:Precancerous Conditions / Q000473:pathology*; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism*; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects; D014704:Veratrum Alkaloids / Q000494:pharmacology
D053823:Hedgehog Proteins; D016271:Proto-Oncogene Proteins c-myc; D014704:Veratrum Alkaloids; C000541:cyclopamine